Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, giving promising progress across several healthcare and industrial programs. With its structural similarity to In a natural way derived human serum albumin, OsrHSA delivers a safer, additional trustworthy substitute for therapeutic